Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.

01 Feb 2021
0

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.

Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*.

Glycoconj J. 2021 Feb;38(1):55-65.

Tags

Share this

Related Posts

A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia. Ratanabanangkoon K, Tan KY, Eursakun S, Tan CH, Simsiriwong P, Pamornsakda T, Wiriyarat W, Klinpayom C, Tan NH PLoS Negl Trop Dis 2016, 10(4):e0004565.
Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: Results of a World Health Organization review. Cohen Hubal, E. A., de Wet, T., Du Toit, L., Firestone, M. P., Ruchirawat, M., van Engelen, J., & Vickers, C. (2014). Regulatory Toxicology and Pharmacology, 69(1), 113-124.

Recent Posts